FVP-21489-14947
2 vaccinations
5 coded responses
15 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 784 / TX
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QV3-21841-24143
Child or adolescent in my care · Male · 2021-08-27
JRE-12543-36253
Child or adolescent in my care · Male · 2021-11-07
5HE-17093-61557
Child or adolescent in my care · Female · 2021-11-07
SDF-82041-15525
Child or adolescent in my care · Male · 2021-11-07
Timeline
-
2021-02-23
Dose 1 — Moderna
-
2021-03-19
Registered in v-safe
-
2021-03-19
Survey response — day 21, dose 1MedDRA: Lymphadenopathy, Musculoskeletal stiffness — Feeling: GoodFree text: Stiffness on both sides of my neck, swollen glands/lymph nodes along throat and breast/underarms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Dose 2 — Moderna
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Flatulence — Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painFree text: Intestinal gas overnightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
-
2021-04-06
Survey response — day 14, dose 2MedDRA: Headache, Pyrexia — Feeling: GoodFree text: Headache and low-grade fever on 4/3/2021.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
- 2021-04-22
- 2021-04-27
-
2021-05-04
Survey response — day 42, dose 2MedDRA: Anxiety, Eye disorder, Headache, Pre-existing disease — Feeling: GoodFree text: Eyes over- and under-dilated. Increase in anxiety attacks. Pain in the top of my head/brain, off and on over the past six weeks. Unsure of any relation to the vaccine, but listing what other health issues I have encountered recently.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-22
-
2021-09-21
Survey response — 6 months, dose 2MedDRA: Diplopia, Miosis, Office visit, Vision blurred — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Tonic pupil in my left eye. Double or blurred vision. · Healthcare visit (other): Primary care physician, ophthalmologist, neurologist, and neurologist specialistMedDRA releases: 2024-11 · check-in free text available
-
2021-09-21
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-23
-
2021-12-07
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Moderna | |
| 2 | 2021-03-23 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 5 — day 21, dose 1
Symptoms: Stiffness on both sides of my neck, swollen glands/lymph nodes along throat and breast/underarms.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Intestinal gas overnight
Release 7 — day 14, dose 2
Symptoms: Headache and low-grade fever on 4/3/2021.
Release 8 — day 42, dose 2
Symptoms: Eyes over- and under-dilated. Increase in anxiety attacks. Pain in the top of my head/brain, off and on over the past six weeks. Unsure of any relation to the vaccine, but listing what other health issues I have encountered recently.
Release 9 — 6 months, dose 2
Symptoms: Tonic pupil in my left eye. Double or blurred vision.
Healthcare visit (other): Primary care physician, ophthalmologist, neurologist, and neurologist specialist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Diplopia | · | · | ✓ |
| SD | Eye disorder | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Miosis | · | · | ✓ |
| SD | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SRO | Flatulence | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release